University of Utah Hospital Purchases IMRISNV

March 28, 2011
             --Leading stroke facility to study patient benefits --

WINNIPEG, March 28 /PRNewswire/ – (NASDAQ: IMRS) (TSX: IM) – IMRIS Inc. (“IMRIS” or the “Company”) today announced the sale of
IMRISNV to University of Utah Hospital in Salt Lake City, Utah.

IMRISNV will provide important new capabilities for clinicians at
University of Utah Hospital’s leading edge stroke center. IMRISNV
combines the imaging modalities of MR and fluoroscopy in a fully
integrated suite to assist clinicians in the diagnosis and treatment of
stroke and other neurovascular disorders. The system permits a patient
to be transitioned quickly and seamlessly between assessment, using MR
imaging, and intervention, using fluoroscopy guidance without the need
to transport the patient between imaging modalities. During and
immediately after a procedure, new MR images can be taken to assess the
effectiveness of the treatment and to determine if further intervention
is required.

In addition to an interventional theatre for stroke and other
neurovascular procedures, the system at University of Utah Hospital
will also include adjoining rooms for neurosurgical and diagnostic
imaging. The interventional theatre for treating stroke patients will
feature an advanced bi-plane angiography system and a wide bore 3T MR
scanner. The high-field MR scanner can be deployed into any of the
three rooms in the IMRIS suite. When not in use for intra operative
imaging, both the MR and fluoroscopic system are available for
diagnostic use.

The University of Utah (U of U) has been designated a Stroke Center of
Excellence by Chicago-based think tank NeuStrategy. The U of U Stroke
Center’s “Institute” level certification, which is the highest
recognition possible, signifies use of the most advanced technology,
dedicated care for stroke patients, specialty-trained physicians and
staff, and focused research to improve stroke care and outcomes. The U
of U Stroke Center is also a Joint Commission Certified Primary Stroke
Center and has been recognized by the American Heart and Stroke
Association as providing the highest level of care for the stroke
patients with the “Get with the Guidelines Gold Plus Certification”.

In conjunction with the installation of IMRISNV, University of Utah
Hospital will be undertaking a study to assess the capabilities and
benefits of the IMRISNV system. Under the direction of Dr. Steve
Stevens, Professor and Chair of the Department of Radiology at the
University of Utah, the study will track and evaluate how IMRISNV
contributes to the Neuroscience team’s management of stroke and to the
outcomes of its patients.

“The impact an ischemic stroke has on a patient is currently directly
correlated to the length of time from stroke onset to treatment,” said
Dr. Stevens. ” With IMRISNV, we will have the ability to quickly and
accurately assess the stroke patient’s brain using MR imaging and if
indicated immediately undertake an interventional procedure using
fluoroscopic guidance to resolve the condition. We believe the
availability of MR imaging and fluoroscopy together in a fully
integrated interventional environment will allow us to significantly
advance our ability to identify and appropriately treat patients who
suffer an ischemic stroke independent of time of onset.”

“University of Utah Hospital is an established leader in stroke care and
we are pleased to be collaborating with Dr. Stevens and his team,” said
David Graves, IMRIS Chairman & CEO. “We believe IMRISNV will make an
important contribution to improving outcomes for stroke patients and
the addition of study data from University of Utah’s Clinical
Neurosciences Center will further demonstrate the capabilities of

Today’s announcement marks the second IMRIS system for University of
Utah Health Care. In late 2009, Huntsman Cancer Hospital selected an
IMRISneuro system. In the last ten years, Huntsman Cancer Institute has
grown to become one of America’s major cancer research centers.


IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions.
These solutions feature fully integrated surgical and interventional
suites that incorporate magnetic
resonance, fluoroscopy and computed tomography to deliver on demand
imaging during procedures.
The Company’s systems serve the neurosurgical, cardiovascular and
neurovascular markets and
have been selected by leading medical institutions around the world.


Source: newswire

comments powered by Disqus